• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制备[61Cu]-2-乙酰基吡啶硫代半卡巴腙配合物作为一种可能用于恶性肿瘤的正电子发射断层显像(PET)示踪剂。

Preparation of [61Cu]-2-acetylpyridine thiosemicarbazone complex as a possible PET tracer for malignancies.

作者信息

Jalilian A R, Rowshanfarzad P, Sabet M, Shafiee A

机构信息

Cyclotron and Nuclear Medicine Department, Nuclear Research Center for Agriculture and Medicine, Atomic Energy Organization of Iran, Rajaeeshahr, P.O. Box 31485-498 Karaj, Iran.

出版信息

Appl Radiat Isot. 2006 Mar;64(3):337-41. doi: 10.1016/j.apradiso.2005.08.002. Epub 2005 Nov 15.

DOI:10.1016/j.apradiso.2005.08.002
PMID:16293418
Abstract

Due to the interesting anti-proliferative properties of copper-thiosemicarbazone complexes, the production of a (61)Cu-labeled thiosemicarbazone, i.e. 2-acetylpyridine thiosemicarbazone (APTS) was investigated. Copper-61 (T(1/2)=3.33 h) was produced via the (64)Zn(p,alpha)(61)Cu nuclear reaction using a natural zinc target irradiated with 22 MeV protons for 500 microAh. The (61)Cu was separated from the irradiated target material by a two-step method and converted to acetate; this yielded a final activity of 222 GBq (6.0 Ci), with a radiochemical yield of >95%. The (61)Cu-acetate was mixed with 2-acetylpyridine thiosemicarbazone for 30 min at room temperature to yield [(61)Cu]APTS with a radiochemical yield of more than 80%. Colorimetric methods showed that residual chemical impurities in the product were below the accepted limits. Radio thin layer chromatography (RTLC) showed a radiochemical purity of more than 99% after C(18) column chromatography. A specific activity of about 370-740 MBq/mmol (10-20 Ci/mmol) was obtained. The stability of the final product was checked in the absence and presence of human serum at 37 degrees C for up to 3 h. The partition coefficient of the final complex was also determined.

摘要

由于铜硫代卡巴腙配合物具有有趣的抗增殖特性,因此对一种(61)Cu标记的硫代卡巴腙即2-乙酰基吡啶硫代卡巴腙(APTS)的制备进行了研究。通过(64)Zn(p,α)(61)Cu核反应,使用天然锌靶在22 MeV质子照射下500微安时来制备铜-61(T(1/2)=3.33小时)。通过两步法将(61)Cu与辐照后的靶材料分离并转化为醋酸盐;最终活度为222 GBq(6.0 Ci),放射化学产率>95%。将(61)Cu-醋酸盐与2-乙酰基吡啶硫代卡巴腙在室温下混合30分钟,得到放射化学产率超过80%的[(61)Cu]APTS。比色法表明产品中的残留化学杂质低于可接受限度。放射性薄层色谱法(RTLC)显示在C(18)柱色谱后放射化学纯度超过99%。获得了约370-740 MBq/mmol(10-20 Ci/mmol)的比活度。在37℃下,在有无人血清存在的情况下对最终产品的稳定性进行了长达3小时的检查。还测定了最终配合物的分配系数。

相似文献

1
Preparation of [61Cu]-2-acetylpyridine thiosemicarbazone complex as a possible PET tracer for malignancies.制备[61Cu]-2-乙酰基吡啶硫代半卡巴腙配合物作为一种可能用于恶性肿瘤的正电子发射断层显像(PET)示踪剂。
Appl Radiat Isot. 2006 Mar;64(3):337-41. doi: 10.1016/j.apradiso.2005.08.002. Epub 2005 Nov 15.
2
Preparation and evaluation of [(61)Cu]-thiophene-2-aldehyde thiosemicarbazone for PET studies.
Nucl Med Rev Cent East Eur. 2008;11(2):41-7.
3
Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging.[61铜]ATSM作为用于纤维肉瘤成像的正电子发射断层显像(PET)放射性药物的临床前研究。
Acta Pharm. 2009 Mar;59(1):45-55. doi: 10.2478/v10007-009-0008-9.
4
64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumors.64Cu-氮杂双环[3.2.2]壬烷硫代半卡巴腙配合物:用于肿瘤拓扑异构酶II表达正电子发射断层显像的放射性药物。
J Nucl Med. 2006 Dec;47(12):2034-41.
5
Performance of a ⁶²Zn/⁶²Cu microgenerator in kit-based synthesis and delivery of [⁶²Cu]Cu-ETS for PET perfusion imaging.⁶²Zn/⁶²Cu微型发生器在基于试剂盒的[⁶²Cu]Cu-ETS合成及PET灌注成像给药中的性能
Appl Radiat Isot. 2014 Sep;91:38-43. doi: 10.1016/j.apradiso.2014.05.006. Epub 2014 May 22.
6
Photoactivatable bis(thiosemicarbazone) derivatives for copper-64 radiotracer synthesis.用于铜 64 放射性示踪剂合成的光活化双(硫代氨基甲肟)衍生物。
Dalton Trans. 2022 Mar 29;51(13):5041-5052. doi: 10.1039/d2dt00209d.
7
Production of 61Cu using natural cobalt target and its separation using ascorbic acid and common anion exchange resin.使用天然钴靶生产61Cu及其用抗坏血酸和普通阴离子交换树脂进行分离。
Appl Radiat Isot. 2012 Feb;70(2):365-8. doi: 10.1016/j.apradiso.2011.10.011. Epub 2011 Nov 4.
8
Establishing Reliable Cu-64 Production Process: From Target Plating to Molecular Specific Tumor Micro-PET Imaging.建立可靠的铜-64生产工艺:从靶材镀覆到分子特异性肿瘤微PET成像。
Molecules. 2017 Apr 17;22(4):641. doi: 10.3390/molecules22040641.
9
Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions.用于制备铜放射性药物的混合双(硫代半卡巴腙)配体:含两种不同硫代半卡巴腙官能团的四齿配体的合成与评价
J Med Chem. 1997 Jan 3;40(1):132-6. doi: 10.1021/jm9605703.
10
Nuclear model analysis of excitation functions of proton, deuteron and α-particle induced reactions on nickel isotopes for production of the medically interesting copper-61.用于生产具有医学意义的铜-61的质子、氘核和α粒子与镍同位素引发反应的激发函数的核模型分析。
Appl Radiat Isot. 2014 Jul;89:65-73. doi: 10.1016/j.apradiso.2014.02.007. Epub 2014 Feb 19.

引用本文的文献

1
Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets.从液体靶标生产符合药品生产质量管理规范(GMP)的临床用量的铜-61放射性药物。
Pharmaceuticals (Basel). 2022 Jun 7;15(6):723. doi: 10.3390/ph15060723.
2
Development of copper based drugs, radiopharmaceuticals and medical materials.开发基于铜的药物、放射性药物和医用材料。
Biometals. 2012 Dec;25(6):1089-112. doi: 10.1007/s10534-012-9578-y. Epub 2012 Aug 23.